Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty (THA): Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00358735

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:49.282916+00:00

Published At

2014-10-21T00:00:00+00:00

Record Updated At

2014-10-30

Results Posted At

2014-10-21

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Deep Vein Thrombosis of Lower Limb", "Pulmonary Embolism (PE)", "Bleeding"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2014-10-30"

protocolSection.identificationModule.nctId

"NCT00358735"

protocolSection.identificationModule.officialTitle

"Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty (THA): Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2014-10-21"

Study condition terms

• Deep Vein Thrombosis of Lower Limb (protocolSection.conditionsModule.conditions)
• Pulmonary Embolism (PE) (protocolSection.conditionsModule.conditions)
• Bleeding (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.